RGLS

Regulus Therapeutics
RGLS

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

RGLS was delisted on the 24th of June, 2025.

Back to rankings

25 hedge funds and large institutions have $15M invested in Regulus Therapeutics in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 12 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

less funds holding

Funds holding: →

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
25
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$580K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.43M
2
+$817K
3
+$736K
4
PCM
Prelude Capital Management
New York
+$59.8K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$55.9K

Top Sellers

1
-$15.4K
2
-$5.88K
3
-$417
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$5.7M
2
$3.24M
3
$2.86M
4
$1.63M
5
$416K
6
$326K
7
$272K
8
$166K
9
$68K
10
$61.3K
11
$59.8K
12
$40.9K
13
$27.2K
14
$26.4K
15
$26K
16
$15.2K
17
$11.5K
18
$5.31K
19
$1.01K
20
$908
21
$187
22
$73
23
–
24
–